Results 6,921-6,940 of 7,777 for speaker:Joe Costello
- Public Accounts Committee: Special Report 90 of the Northern Ireland Audit Office and the Office of the Comptroller and Auditor General
The Bytel Project (16 Apr 2015) Joe Costello: Is that not major negligence? Taxpayers' money was spent but obviously no verification was done. Had verification been done, it would have been obvious that this was not right. To make matters worse, it was a sister entity of Bytel which provided these obsolete goods so there are other questions to be answered in that regard.
- Public Accounts Committee: Special Report 90 of the Northern Ireland Audit Office and the Office of the Comptroller and Auditor General
The Bytel Project (16 Apr 2015) Joe Costello: Was it known at the time that they were obsolete and could not be used?
- Public Accounts Committee: Special Report 90 of the Northern Ireland Audit Office and the Office of the Comptroller and Auditor General
The Bytel Project (16 Apr 2015) Joe Costello: That was not known at the time. Is Deloitte included in the statement of claim?
- Public Accounts Committee: Special Report 90 of the Northern Ireland Audit Office and the Office of the Comptroller and Auditor General
The Bytel Project (16 Apr 2015) Joe Costello: But Deloitte gave a clean bill of health for €1.3 million?
- Public Accounts Committee: Business of Committee (23 Apr 2015)
Joe Costello: Are we doing a report on the Docklands and the Jeanie Johnston?
- Public Accounts Committee: Business of Committee (23 Apr 2015)
Joe Costello: The Comptroller and Auditor General was to do more work regarding Thornton Hall, the proposed prison in north county Dublin that cost €50 million but which remains incomplete. The Department indicated that it had established an expert group to consider the future of the site. The Department had installed sanitation in all the cells. Since the decision was taken not to go ahead, the...
- Public Accounts Committee: Business of Committee (23 Apr 2015)
Joe Costello: Could I also ask for an update on the expert group that is examining the future?
- Public Accounts Committee: Business of Committee (23 Apr 2015)
Joe Costello: First, I welcome the suggestion by the Taoiseach that this matter might be dealt with by the PAC and, by extension, I presume that, if legislation was required, such legislation would be provided. It is something that we have been expressing to some degree in regard to some of the limitations on our work. If that can be enhanced by an extension through legislation, that should be welcomed...
- Public Accounts Committee: Business of Committee (23 Apr 2015)
Joe Costello: No, but if one takes it that our remit is to deal with the taxpayer, and the taxpayer had put €34 billion into IBRC itself, then an entity that came under that also became part and parcel of what was both guaranteed by the bank guarantee and was effectively in State ownership - in other words, the assets were linked to IBRC. At that point in time, are we not talking about the...
- Public Accounts Committee: Business of Committee (23 Apr 2015)
Joe Costello: It happened yesterday morning.
- Public Accounts Committee: Business of Committee (23 Apr 2015)
Joe Costello: I think they did it in a very circuitous way. They did not contact me. They contacted the Committee of Public Accounts to say they were arranging a meeting with various stakeholders. They did not formally invite us to go along, but I dropped along anyway. I do not know whether that fulfils the requirements here. I think it was specifically requested that the Department would meet me on...
- Public Accounts Committee: Business of Committee (23 Apr 2015)
Joe Costello: I appreciate that.
- Public Accounts Committee: 2013 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 39 - Health Service Executive
Chapter 14 - Procurement by the Health Service Executive
Health Service Executive Financial Statements 2013 (23 Apr 2015) Joe Costello: Yes. I welcome the witnesses to the Committee of Public Accounts. I have a number of questions. One of the issues I am concerned about is the cost of drugs. We seem to be the most expensive country in the world in terms of drugs purchase. The drugs bill for the Health Service Executive, HSE, is approximately €2 billion. Have we any clear indication as to the reason we have not...
- Public Accounts Committee: 2013 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 39 - Health Service Executive
Chapter 14 - Procurement by the Health Service Executive
Health Service Executive Financial Statements 2013 (23 Apr 2015) Joe Costello: Can Mr. O'Brien give us an idea of the success in terms of percentage decrease?
- Public Accounts Committee: 2013 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 39 - Health Service Executive
Chapter 14 - Procurement by the Health Service Executive
Health Service Executive Financial Statements 2013 (23 Apr 2015) Joe Costello: That figure relates only to generic drugs.
- Public Accounts Committee: 2013 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 39 - Health Service Executive
Chapter 14 - Procurement by the Health Service Executive
Health Service Executive Financial Statements 2013 (23 Apr 2015) Joe Costello: That is a drop in the ocean, out of €2 billion.
- Public Accounts Committee: 2013 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 39 - Health Service Executive
Chapter 14 - Procurement by the Health Service Executive
Health Service Executive Financial Statements 2013 (23 Apr 2015) Joe Costello: These are all still patent drugs. It is not that the patent has run out.
- Public Accounts Committee: 2013 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 39 - Health Service Executive
Chapter 14 - Procurement by the Health Service Executive
Health Service Executive Financial Statements 2013 (23 Apr 2015) Joe Costello: Is it not the case that the majority of drugs have gone off patent at this stage? There was a huge dip in terms of exports last year because so many of the drug companies had gone off patent.
- Public Accounts Committee: 2013 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 39 - Health Service Executive
Chapter 14 - Procurement by the Health Service Executive
Health Service Executive Financial Statements 2013 (23 Apr 2015) Joe Costello: Has the HSE tracked that in an effort to determine whether that has been channelled into the reduction achieved?
- Public Accounts Committee: 2013 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 39 - Health Service Executive
Chapter 14 - Procurement by the Health Service Executive
Health Service Executive Financial Statements 2013 (23 Apr 2015) Joe Costello: No, this is not reference pricing. That is the deal that the HSE has done with the pharmaceutical companies.